Lam Research's fiscal fourth-quarter results carry outsized importance as a bellwether for the broader semiconductor equipment industry. As a leading supplier of wafer fabrication equipment — particularly in etch and deposition — LRCX's performance reflects the health of global chip manufacturing investment. The June quarter report arrived at a moment when AI-driven infrastructure spending is reshaping the semiconductor landscape, with major chipmakers committing to multi-year fab construction plans. Following four consecutive quarters of record revenue and a 165% stock surge over the prior 52 weeks, expectations were elevated. This earnings release served as a critical checkpoint on whether AI-related demand can sustain the company's extraordinary growth trajectory and whether elevated valuation multiples remain justified.
LRCX posted June quarter revenue of $6.72 billion, a 15% sequential increase and 30% year-over-year growth, exceeding both the midpoint of management's guidance range and the Wall Street consensus. Non-GAAP diluted earnings per share came in at $1.82, beating analyst estimates by $0.13 to $0.14 per share. GAAP net income rose to $2.28 billion, or $1.81 per share, compared with $1.72 billion, or $1.35 per share, in the same quarter a year ago.
The standout metric was profitability. Non-GAAP gross margin reached 52.0%, a level the company has not achieved in two decades, driven by pricing actions, operational efficiencies, favorable product mix, and scale benefits. Non-GAAP operating margin expanded to 38.4%, a record. The Customer Support Business Group (CSBG) delivered its third consecutive record quarter at nearly $2.5 billion, up 17% sequentially and 43% year-over-year, fueled by record upgrade revenue and growing adoption of Equipment Intelligence-enabled services.
Memory accounted for 46% of systems revenue, up from 39% in the prior quarter, led by a doubling of NAND revenue as customers accelerated conversions to 256-layer and higher devices for enterprise solid-state drives. DRAM (dynamic random-access memory) revenue held roughly flat at record levels. Foundry represented 44% of systems revenue, with investment in 2-nanometer and 3-nanometer nodes and advanced packaging largely offsetting lower mature-node spending from Chinese customers.
For the full fiscal year 2026, Lam Research reported record revenue of $23.23 billion and diluted EPS of $5.82, rising 26% and 41%, respectively, from fiscal 2025. I also checked comparable names in the sector using Tickeron’s AI Screener to see how LRCX stacks up on key metrics.
Market reaction to Lam Research's results was notably bifurcated. Shares fell 7.04% during regular trading on July 29, closing at $250.63, as broader market jitters and potentially some profit-taking weighed on the stock ahead of the print. However, the after-market response told a different story: the stock rebounded 5.31% to approximately $265.75 as investors absorbed the magnitude of the earnings beat and, more importantly, the September quarter guidance that handily exceeded consensus. The after-hours recovery suggests that while some caution had been priced in — perhaps around China exposure or sustainability of NAND demand — the forward outlook was sufficiently compelling to restore bullish sentiment. With the company having now beaten EPS estimates in every quarter for at least the past year, investor confidence in management's execution and the durability of AI-driven equipment demand remains a central theme.
Lam Research raised its calendar 2026 wafer fabrication equipment (WFE) spending forecast to the low-$150 billion range, up from a prior estimate of approximately $140 billion. This upward revision, paired with September quarter guidance calling for $8.1 billion in revenue and non-GAAP EPS of $2.15, signals management's conviction that the current upcycle has substantial runway ahead.
Several factors will shape the quarters ahead. First, the sustainability of NAND-related spending will be a focal point. Management indicated that roughly $40 billion in NAND conversion investments is being pulled forward, with the majority expected before the end of calendar 2027. Investors will monitor whether this pull-forward represents durable demand or borrows from future periods.
Second, China exposure remains a variable. Mature-node spending from Chinese customers declined during the quarter, offset by advanced-node investments elsewhere. Any further regulatory tightening on semiconductor equipment exports could introduce headwinds.
Third, Lam's expanding served available market (SAM) — which management expects to reach slightly above the mid-30s percentage of total WFE — and growing advanced packaging revenue (projected to rise more than 50% in calendar 2026) represent structural growth drivers that could outlast cyclical fluctuations. The company's investment in robotics, collaborative maintenance tools, and Equipment Intelligence services also positions CSBG as a recurring revenue engine that may help smooth equipment-cycle volatility over time.
Finally, with the stock trading at a forward price-to-earnings ratio well above the semiconductor industry average, the burden remains on Lam Research to continue delivering outsized growth to support its premium valuation. The September quarter will provide the next major checkpoint. From what I see, these trends warrant close attention in the coming months.
In my research process, I frequently use Tickeron’s AI Screener to quickly filter semiconductor equipment stocks and compare metrics like margins, growth rates, and AI signals against peers. This helps surface ideas that align with the themes I’m tracking without manually scanning thousands of securities.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
It is expected that a price bounce should occur soon.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LRCX advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .
LRCX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on July 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LRCX as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for LRCX turned negative on July 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at .
LRCX moved below its 50-day moving average on July 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for LRCX crossed bearishly below the 50-day moving average on July 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LRCX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for LRCX entered a downward trend on July 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LRCX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LRCX's P/B Ratio (29.851) is very high in comparison to the industry average of (7.608). P/E Ratio (43.811) is within average values for comparable stocks, (73.854). Projected Growth (PEG Ratio) (1.456) is also within normal values, averaging (1.387). Dividend Yield (0.004) settles around the average of (0.007) among similar stocks. P/S Ratio (14.749) is also within normal values, averaging (76.812).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of semiconductor processing equipment
Industry ElectronicProductionEquipment